Pernix Therapeutics competitorsClear all

Pernix Therapeutics's top competitors include Moderna, Alnylam Pharmaceuticals, Celyad and Sorrento Therapeutics.
Pernix Therapeutics
Pernix Therapeutics
Pernix Therapeutics is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products primarily for the pediatric market.
Moderna
Moderna
Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Celyad
Celyad
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
Sorrento Therapeutics
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Founding Date
Founding Date
N/A
Founding Date
N/A
Founding Date
2002
Founding Date
2007
Founding Date
2006
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Morristown, US HQ
Locations
Cambridge, US HQ
Huddinge, SE
Cambridge, US
Norwood, US
Chicago, US
Huntington, US
Locations
Cambridge, US HQ
Paris, FR
Milano, IT
Amsterdam, NL
Stockholm, SE
Zug, CH
Maidenhead, GB
Locations
Mont-Saint-Guibert, BE HQ
New York, US
Locations
San Diego, US HQ
San Diego, US
Employees
Employees
171
Employees
8309% increase
Employees
1,32324% increase
Employees
105
Employees
31019% decrease
Valuation ($)
Valuation ($)
3 m
Valuation ($)
26.5 b
Valuation ($)
15.6 b
Valuation ($)
131.4 m
Valuation ($)
2.4 b
Twitter followers
Twitter followers
308
Twitter followers
37.4 k
Twitter followers
13.1 k
Twitter followers
2.3 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
17
Number of tweets (last 30 days)
28
Number of tweets (last 30 days)
7
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
232.4
Average likes per tweet (last 30 days)
7.1
Average likes per tweet (last 30 days)
4.1
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
114893
Alexa Website Rank
294228
Alexa Website Rank
286915
Alexa Website Rank
165862
Employee Rating
Employee Rating
2.2
Employee Rating
3.7
Employee Rating
3.9
Employee Rating
3.3
Employee Rating
2.9

Financial

Revenue (est.)
Revenue (est.)
$146.1m (FY, 2017)
Revenue (est.)
$60.2m (FY, 2019)
Revenue (est.)
$219.8m (FY, 2019)
Revenue (est.)
€3.5m (FY, 2017)
Revenue (est.)
$31.4m (FY, 2019)
Cost of goods
Cost of goods
$44.6m (FY, 2017)
Cost of goods
N/A
Cost of goods
$25.1m (FY, 2019)
Cost of goods
€515k (FY, 2017)
Cost of goods
N/A
Gross profit
Gross profit
$101.4m (FY, 2017)
Gross profit
N/A
Gross profit
$194.7m (FY, 2019)
Gross profit
€3m (FY, 2017)
Gross profit
N/A
Net income
Net income
($77.1m) (FY, 2017)
Net income
($514m) (FY, 2019)
Net income
($886.1m) (FY, 2019)
Net income
(€56.4m) (FY, 2017)
Net income
($363m) (FY, 2019)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 1.8b
Total funding raised
$ 1.5b
Total funding raised
N/A
Total funding raised
$ 42.6m
For sources of this data, please see the company profile

View company profiles

Moderna
HQ
Cambridge, US
Employees
830↑ 9% increase

Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.

View company
Alnylam Pharmaceuticals
HQ
Cambridge, US
Employees
1,323↑ 24% increase

Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.

View company
Celyad
HQ
Mont-Saint-Guibert, BE
Employees
105

Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.

View company
Sorrento Therapeutics
HQ
San Diego, US
Employees
310↓ 19% decrease

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

View company